Prescient Therapeutics Ltd

ASX:PTX ISIN:AU000000PTX3

Prescient Therapeutics Limited is a clinical-stage oncology company. The Company's principal activities include in-licensing of intellectual property; the preparation for and conduct of clinical trials relating to the Company's products; business development associated with the promotion of its technologies and products, and business development associated with developing collaborative, partnership relationships and corporate transactions. 
 
           

Voir en d'autres langues

Nouvelles

###

141,324 COMPANY PROFILE VIEWS

  • This Page Viewed: (7 derniers jours: 16) (Last 30 Days: 100) (Since Published: 10857) 

Company Data

    Fax
  • (03) 9853 5134 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.virax.com.au/

More News Results

  • 2025/07/15: Update - Proposed issue of securities - PTX*
  • 2025/07/15: Prescient Therapeutics Extends Share Purchase Plan*
  • 2025/07/14: Notification of cessation of securities - PTX*
  • 2025/07/08: Notification of cessation of securities - PTX*
  • 2025/07/04: Prescient Share Purchase Plan Investor Presentation*
  • 2025/07/02: Prescient Therapeutics Opens Share Purchase Plan*
  • 2025/07/02: Share Purchase Plan Cleansing Notice*
  • 2025/07/01: Proposed issue of securities - PTX*
  • 2025/07/01: Prescient Therapeutics Launches Share Purchase Plan for $7m*
  • 2025/06/02: Change of Registered Office and Principal Place of Business*
*refer to company website